Anti-Helicobacter pylori ureA/Urease subunit alpha Polyclonal Antibody from ProteoGenix; catalogue ARO-A22512; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-Helicobacter pylori ureA/Urease subunit alpha Polyclonal Antibody – the ultimate solution for your biotech research needs.
This highly specific antibody targets the ureA/Urease subunit alpha protein, an essential component of the Helicobacter pylori bacteria. Helicobacter pylori is a common pathogen that causes various gastrointestinal diseases, including gastritis, peptic ulcers, and even stomach cancer. The ureA/Urease subunit alpha protein plays a crucial role in the bacteria’s survival and virulence, making it an attractive target for therapeutic interventions.
Our Anti-Helicobacter pylori ureA/Urease subunit alpha Polyclonal Antibody is a powerful tool for studying the role of this protein in Helicobacter pylori infections. It has been extensively validated for its specificity and sensitivity, ensuring accurate and reliable results in your experiments.
This antibody is suitable for a wide range of applications, including Western blotting, immunofluorescence, and immunohistochemistry. Its high affinity and selectivity make it an ideal choice for detecting and quantifying ureA/Urease subunit alpha in various biological samples.
One of the key benefits of using our Anti-Helicobacter pylori ureA/Urease subunit alpha Polyclonal Antibody is its versatility. It has been successfully used in both in vitro and in vivo studies, providing valuable insights into the role of the ureA/Urease subunit alpha protein in Helicobacter pylori infections. Its use has also been reported in numerous publications, demonstrating its reliability and effectiveness in research.
In addition to its main application in Helicobacter pylori research, this antibody has also shown potential for use in diagnostic assays and as a therapeutic agent. Its ability to specifically bind to the ureA/Urease subunit alpha protein makes it a promising candidate for developing targeted treatments against Helicobacter pylori infections.
With our Anti-Helicobacter pylori ureA/Urease subunit alpha Polyclonal Antibody, you can confidently advance your research on this pathogenic bacteria and its associated diseases. Its exceptional performance and proven track record make it a valuable asset for any biotech laboratory. Order now and take your Helicobacter pylori research to the next level.
ProteoGenix catalogue number ARO-A22512. For research use only.
Target: urease subunit alpha, ureA; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| urease subunit alpha, ureA |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
